Spontaneous coronary artery dissection: An uncommon but dangerous condition Joseph S. Alpert Editor’s Commentary Pages: 233 - 234
Acute coronary syndromes in women: Is treatment different? should it be? Susan K. BennettRita F. Redberg OriginalPaper Pages: 243 - 252
Markers to define ischemia: Are they ready for prime time use in patients with acute coronary syndromes? Jesse Adams OriginalPaper Pages: 253 - 258
Eplerenone: Will it have a role in the treatment of acute coronary syndromes? David J. MeierBertram PittSanjay Rajagopalan OriginalPaper Pages: 259 - 263
Clopidogrel: How good is it and how does it work? Richard A. Santa-CruzSteven R. Steinhubl OriginalPaper Pages: 264 - 268
Individualizing therapy in acute coronary syndromes: Using a multiple biomarker approach for diagnosis, risk stratification, and guidance of therapy Vivian Y. MoJames A. de Lemos OriginalPaper Pages: 273 - 278
Current concepts in the antithrombotic management of non-ST-elevation acute coronary syndromes David E. Kandzari OriginalPaper Pages: 279 - 286
Use of the early invasive approach in the management of acute coronary syndromes Jorge F. SaucedoThomas A. Hennebry OriginalPaper Pages: 287 - 291
Transport and centralization of acute coronary syndrome care James L. OrfordPeter B. Berger OriginalPaper Pages: 292 - 299
The evaluation and management of dyslipidemia and impaired glucose metabolism during acute coronary syndromes Abhinav GoyalJohn L. PetersenKenneth W. Mahaffey OriginalPaper Pages: 300 - 307